Bone Loss
Also known as: Osteopenia / Osteopenia (disorder) / Osteopenia (morphologic abnormality) / Osteopaenia
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB06643 | Denosumab | A RANK ligand (RANKL) inhibitor used for the management of osteoporosis in patients at high risk for bone fractures. |
| DB14151 | Phosphorus | A medication indicated in the treatment of hypophosphatemia. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB06643 | Denosumab | Tumor necrosis factor ligand superfamily member 11 | target |